MedTrace Logo

A Unified Treatment for Anxiety Disorders

NCT00586001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2018-12-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to develop a new psychological therapy for a variety of different types of emotional disorders. The study will compare symptoms and functioning of clients who receive the treatment with those who do not, and will include a number of assessments before, during, and after treatment. We predict that patients receiving active treatment will show improved functioning relative to wait-list control.

Conditions

  • Emotional Disorders
  • Anxiety Disorders

Interventions

BEHAVIORAL

Unified Protocol for Transdiagnostic Treatment of Emotional Disorders

Cognitive-behavioral treatment in development for emotional disorders

Sponsors & Collaborators

  • Boston University Charles River Campus

    lead OTHER

Principal Investigators

  • David H Barlow, Ph.D · Boston University Center for Anxiety and Related Disorders

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2008-11-30
Completion
2010-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00586001 on ClinicalTrials.gov